Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103880755A reveals a green catalytic route for 2,4,5-triaryl imidazoles using a biodegradable Brönsted acid, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel synthetic route for Olaparib improves yield and purity significantly. Cost-effective manufacturing solution for pharmaceutical intermediates supply chain reliability and scalability.
Novel patent CN106478525A details an iridium-catalyzed tandem synthesis of quinazolones using oximes, offering high atom economy and simplified purification for pharmaceutical intermediates.
Novel photoredox method for alpha,alpha-difluoro-beta-carbonyl sulfones using visible light, offering mild conditions and broad substrate scope for pharma intermediates.
Patent CN111606913B details AlCl3 catalyzed synthesis offering high purity and cost efficiency for electronic chemical manufacturing supply chains.
Patent CN106554265A reveals a one-step Lewis acid catalyzed route for 1-benzosuberones offering high purity and simplified manufacturing for global pharmaceutical supply chains.
Patent CN110818584B reveals a metal-free visible light method for synthesizing alpha,beta-unsaturated amides, offering cost reduction and scalable pharmaceutical intermediate manufacturing.
Patent CN107460497A enables cost-effective electrochemical Minisci acylation. Eliminate silver catalysts for scalable pharmaceutical intermediate manufacturing.
Patent CN115448912B reveals high-purity posaconazole intermediate synthesis. Enzymatic route offers supply chain stability and cost reduction in API manufacturing.
Patent CN103406148A details high-activity NHC-Pd catalysts for aminocarbonylation. Discover cost-effective synthesis and scalable supply solutions for pharmaceutical intermediates.
Novel metal-free synthesis of isatin exocyclic diene intermediates offering high selectivity and supply chain reliability for pharmaceutical manufacturing.
Patent CN105732568A offers safer chiral intermediate synthesis. Reduces toxic reagents and improves scalability for pharmaceutical manufacturing supply chains globally.
Novel chemical route for Lycibarbarine A and B using D-2-deoxyribose. Significantly reduces synthesis steps and enhances scalability for antidepressant drug development.
Patent CN100360511C details a novel reduction method for cephalosporin intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Discover advanced chiral bisphosphonamide compounds for asymmetric catalysis. Reliable supplier offering cost-effective manufacturing solutions for pharmaceutical intermediates.
Novel ionic liquid catalysis enables high-yield synthesis of 4 5-dihydropyran benzopyran derivatives with significant supply chain and cost advantages for global buyers.
Novel gallium trichloride catalyzed route ensures high yield purity. Significant supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Patent CN116135830B reveals a green synthesis route for 2-tert-amyl anthraquinone. This method offers high purity and supply chain stability for global buyers.
Novel green synthesis method for alpha-bromo-aromatic ketones using Ru(bpy)3Cl2 photocatalyst, offering high selectivity and mild conditions for pharmaceutical intermediates.
Patent CN1293942C reveals a robust Ni(0) catalyst system using metallic nickel powder for efficient adiponitrile synthesis, offering significant cost and stability advantages.